A recent study conducted by van Rensburg et al. showed that another main mediator of the Hippo pathway, TAZ, promotes immune evasion in human NSCLC and breast cancer through PD-L1, and the experimental findings in this study also suggested that YAP is involved in the regulation of PD-L1 [61,62]. The gene discussed is CD274; the disease is breast carcinoma.